
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30th, 2022
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30th, 2022
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18th, 2022
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17th, 2020
Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9th, 2020
APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates
June 8th, 2020
Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
May 4th, 2020
Italian Biotech Startup Racing To Develop A Coronavirus Vaccine
April 21st, 2020
LI Biotech Speeds COVID-19 Vaccine Candidates To Italy
April 15th, 2020
Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
April 15th, 2020